Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 378

1.

Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia.

Whitehead MW, Phillips RH, Sieniawska CE, Delves HT, Seed PT, Thompson RP, Powell JJ.

Helicobacter. 2000 Sep;5(3):169-75.

PMID:
10971683
2.

Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.

Bardhan KD, Morton D, Perry MJ, Sanders DS, Morris P, Rowland A, Thompson M, Mitchell TR, Roberts PM.

Aliment Pharmacol Ther. 2001 Aug;15(8):1199-204.

3.

Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.

Phillips RH, Whitehead MW, Lacey S, Champion M, Thompson RP, Powell JJ.

Helicobacter. 2000 Sep;5(3):176-82.

PMID:
10971684
4.

Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?

Phillips RH, Whitehead MW, Doig LA, Sieniawska CE, Delves HT, Thompson RP, Powell JJ.

Helicobacter. 2001 Jun;6(2):151-6.

PMID:
11422471
5.

Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.

Vaira D, Holton J, Ainley C, Falzon M, Osborn J, D'Anna L, Romanos A, Chandrakumaran K, McNeil I.

Ital J Gastroenterol. 1992 Sep;24(7):400-4.

PMID:
1392023
6.
7.

The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.

Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.

J Dig Dis. 2007 Nov;8(4):211-5.

PMID:
17970879
8.

Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.

Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, SaccĂ  N, Frandina C, Fiocca R, Trimboli V, Pallone F.

Clin Ther. 2001 May;23(5):761-70.

PMID:
11394734
10.

Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains.

Roghani HS, Massarrat S, Pahlewanzadeh MR, Dashti M.

Eur J Gastroenterol Hepatol. 1999 Jul;11(7):709-12.

PMID:
10445787
11.

One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.

Hung WK, Wong WM, Wong GS, Yip AW, Szeto ML, Lai KC, Hu WH, Chan CK, Xia HH, Yuen MF, Fung FM, Tong TS, Ho VY, Lam SK, Wong BC.

Aliment Pharmacol Ther. 2002 Dec;16(12):2067-72.

12.

A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.

Sotudehmanesh R, Malekzadeh R, Fazel A, Massarrat S, Ziad-Alizadeh B, Eshraghian MR.

J Gastroenterol Hepatol. 2001 Mar;16(3):264-8.

PMID:
11339416
15.
16.

Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate.

Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD.

Scand J Gastroenterol. 1991 Nov;26(11):1123-31.

PMID:
1754846
17.

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.

Kamberoglou D, Polymeros D, Sanidas I, Doulgeroglou V, Savva S, Patra E, Tzias V.

Aliment Pharmacol Ther. 2001 Sep;15(9):1493-7.

18.

Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.

Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.

Hepatogastroenterology. 2007 Jun;54(76):1293-6.

PMID:
17629092
19.

[Helicobacter pylori eradication therapy with bismuth citrate/amoxycillin combination therapy].

Stanescu A, Mayer D, Gabard B, Jost G, Baczako K, Dragici A, Malfertheiner P.

Leber Magen Darm. 1996 Jan;26(1):32-6. German.

PMID:
8851875
20.

Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.

Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.

Am J Gastroenterol. 2001 May;96(5):1390-5.

PMID:
11374672

Supplemental Content

Support Center